Our laboratory provides state-of-the-art services in the detection of acquired chromosomal abnormalities associated with hematological malignancies and solid tumors. We offer all available cytogenetic techniques to identify the type and nature of complex structural abnormalities present in malignant (cancerous) cells. We also offer fluorescence in situ hybridization testing using disease-specific panels (more than 100 probes) and a high resolution array comparative genomic hybridization (CGH) for detection of loss or gain of 92 percent of cancer genes.
We offer a full range of services for clinicians and researchers from Mount Sinai and beyond, including the following assays:
- Cell culture
- Routine G-banded chromosome analysis
- Interphase and metaphase FISH studies (using more than 100 FISH probes)
- Array CGH (agilent cancer platform)+single nucleotide polymorphisms